VCAM1 and Alzheimer disease: Overall, this could indicate alterations in the vasculature since increased plasma levels of these molecules in other pathological settings, such as peripheral arterial disease, are positively correlated with microvascular impaired endothelium-dependent vasodilation [67]; however, there were also controversial results showing lower levels of VCAM-1 in CSF samples from AD patients compared to controls [65].